148 related articles for article (PubMed ID: 28642046)
1. Prostate-specific antigen percentage: An early predictive tool after iodine-125 interstitial brachytherapy for prostate cancer.
Paoluzzi M; Losa A; Cerboneschi V; Colosimo C; Fontana N; Mangili P; Mignogna M; Nava L; Ravaglia V
Brachytherapy; 2017; 16(5):1000-1006. PubMed ID: 28642046
[TBL] [Abstract][Full Text] [Related]
2. Is prostate-specific antigen percentage decrease predictive of clinical outcome after permanent iodine-125 interstitial brachytherapy for prostate cancer?
Paoluzzi M; Mignogna M; Lorenzini E; Valent F; Fontana N; Pinzi N; Repetti F; Ponchietti R
Brachytherapy; 2012; 11(4):277-83. PubMed ID: 22137870
[TBL] [Abstract][Full Text] [Related]
3. PSA bounce after ¹²⁵I-brachytherapy for prostate cancer as a favorable prognosticator.
Engeler DS; Schwab C; Thöni AF; Hochreiter W; Prikler L; Suter S; Stucki P; Schiefer J; Plasswilm L; Schmid HP; Putora PM
Strahlenther Onkol; 2015 Oct; 191(10):787-91. PubMed ID: 26100965
[TBL] [Abstract][Full Text] [Related]
4. Permanent 125I-seed prostate brachytherapy: early prostate specific antigen value as a predictor of PSA bounce occurrence.
Mazeron R; Bajard A; Montbarbon X; Gassa F; Malet C; Rocher F; Clippe S; Bringeon G; Desmettre O; Pommier P
Radiat Oncol; 2012 Mar; 7():46. PubMed ID: 22449081
[TBL] [Abstract][Full Text] [Related]
5.
Kindts I; Stellamans K; Billiet I; Pottel H; Lambrecht A
Strahlenther Onkol; 2017 Sep; 193(9):707-713. PubMed ID: 28488030
[TBL] [Abstract][Full Text] [Related]
6. Analysis of prostate-specific antigen bounce after I(125) permanent seed implant for localised prostate cancer.
Mitchell DM; Swindell R; Elliott T; Wylie JP; Taylor CM; Logue JP
Radiother Oncol; 2008 Jul; 88(1):102-7. PubMed ID: 18453022
[TBL] [Abstract][Full Text] [Related]
7. Kinetics differences between PSA bounce and biochemical failure in patients treated with 125I prostate brachytherapy.
Kanzaki H; Kataoka M; Nishikawa A; Uwatsu K; Nagasaki K; Nishijima N; Hashine K
Jpn J Clin Oncol; 2015 Jul; 45(7):688-94. PubMed ID: 25888709
[TBL] [Abstract][Full Text] [Related]
8. PSA kinetics and PSA bounce following permanent seed prostate brachytherapy.
Crook J; Gillan C; Yeung I; Austen L; McLean M; Lockwood G
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):426-33. PubMed ID: 17869662
[TBL] [Abstract][Full Text] [Related]
9. Analysis of monotherapy prostate brachytherapy in patients with prostate cancer. Initial PSA and Gleason are important for recurrence?
Galego P; Silva FC; Pinheiro LC
Int Braz J Urol; 2015; 41(2):353-9. PubMed ID: 26005979
[TBL] [Abstract][Full Text] [Related]
10. Prostate specific antigen bounce is related to overall survival in prostate brachytherapy.
Hinnen KA; Monninkhof EM; Battermann JJ; van Roermund JG; Frank SJ; van Vulpen M
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):883-8. PubMed ID: 21300477
[TBL] [Abstract][Full Text] [Related]
11. [PSA bounce phenomenon after transperineal interstitial permanent prostate brachytherapy for localized prostate cancer].
Morita M; Lederer JL; Fukagai T; Shimada M; Yoshida H
Nihon Hinyokika Gakkai Zasshi; 2004 Mar; 95(3):609-15. PubMed ID: 15103924
[TBL] [Abstract][Full Text] [Related]
12. [PSA bounce after permanent implant prostate brachytherapy may mimic a biochemical failure].
Toledano A; Chauveinc L; Flam T; Thiounn N; Solignac S; Timbert M; Rosenwald JC; Cosset JM
Cancer Radiother; 2007 May; 11(3):105-10. PubMed ID: 17158082
[TBL] [Abstract][Full Text] [Related]
13. The Importance of Prostate-specific Antigen (PSA) Nadir and Early Identification of PSA Relapse after 10 Years of Prostate Iodine 125 Seed Brachytherapy in Edinburgh.
McLaren DB; Kerr G; Law AB; Brush JP; Keanie J; Malik J; Keough W; Ronaldson T; Lee J; Kehoe T
Clin Oncol (R Coll Radiol); 2015 Sep; 27(9):519-26. PubMed ID: 26093507
[TBL] [Abstract][Full Text] [Related]
14. Prostate-specific antigen bounce after 125I-brachytherapy for prostate cancer is a favorable prognosticator in patients who are biochemical recurrence-free at 4 years and correlates with testosterone.
Nakai Y; Tanaka N; Asakawa I; Anai S; Miyake M; Morizawa Y; Hori S; Owari T; Fujii T; Yamaki K; Hasegawa M; Fujimoto K
Jpn J Clin Oncol; 2020 Jan; 50(1):58-65. PubMed ID: 31665354
[TBL] [Abstract][Full Text] [Related]
15. Prostate-specific antigen bounce in patients treated before 60 years old by iodine 125 brachytherapy for prostate cancer is frequent and not a prognostic factor.
Charret J; Baumann AS; Eschwege P; Moreau JL; Bernier V; Falk AT; Salleron J; Peiffert D
Brachytherapy; 2018; 17(6):888-894. PubMed ID: 30172752
[TBL] [Abstract][Full Text] [Related]
16. PSA bounce after permanent implant prostate brachytherapy may mimic a biochemical failure: a study of 295 patients with a minimum 3-year followup.
Toledano A; Chauveinc L; Flam T; Thiounn N; Solignac S; Timbert M; Rosenwald JC; Cosset JM
Brachytherapy; 2006; 5(2):122-6. PubMed ID: 16644467
[TBL] [Abstract][Full Text] [Related]
17. Multicenter Evaluation of Biochemical Relapse-Free Survival Outcomes for Intraoperatively Planned Prostate Brachytherapy Using an Automated Delivery System.
Martell K; Husain S; Taussky D; Angyalfi S; Delouya G; Després P; Beaulieu L; Martin AG; Vigneault E
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):895-903. PubMed ID: 28807532
[TBL] [Abstract][Full Text] [Related]
18. Prostate-specific antigen bounce after curative brachytherapy for early-stage prostate cancer: A study of 274 African-Caribbean patients.
Leduc N; Atallah V; Creoff M; Rabia N; Taouil T; Escarmant P; Vinh-Hung V
Brachytherapy; 2015; 14(6):826-33. PubMed ID: 26489920
[TBL] [Abstract][Full Text] [Related]
19. Clinical features of prostate-specific antigen bounce after 125I brachytherapy for prostate cancer.
Kubo K; Wadasaki K; Kimura T; Murakami Y; Kajiwara M; Teishima J; Matsubara A; Nagata Y
J Radiat Res; 2018 Sep; 59(5):649-655. PubMed ID: 30085076
[TBL] [Abstract][Full Text] [Related]
20. Prostate-specific antigen 'bounce' after permanent 125I-implant brachytherapy in Japanese men: a multi-institutional pooled analysis.
Satoh T; Ishiyama H; Matsumoto K; Tsumura H; Kitano M; Hayakawa K; Ebara S; Nasu Y; Kumon H; Kanazawa S; Miki K; Egawa S; Aoki M; Toya K; Yorozu A; Nagata H; Saito S; Baba S
BJU Int; 2009 Apr; 103(8):1064-8. PubMed ID: 19040526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
